[NEO] NeoGenomics, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Precision Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 8.93 Change: 0.14 (1.59%)
Ext. hours: Change: 0 (0%)

chart NEO

Refresh chart

Description: NeoGenomics, Inc., together with its subsidiary, NeoGenomics Laboratories, Inc., operates a network of cancer-focused testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. The company performs analyses for hematopoietic cancers, such as leukemia and lymphoma; and solid tumor cancers comprising breast, lung, colon, and bladder cancer. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry testing services to identify cell proteins in a tissue section; and molecular testing services that focus on the analysis of DNA and RNA, as well as on t

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 11.4% Sales Growth - Q/Q-7.89% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA0.33% ROE0.45% ROI
Current Ratio4.14 Quick Ratio3.95 Long Term Debt/Equity0.15 Debt Ratio0.23
Gross Margin45.2% Operating Margin1.37% Net Profit Margin0.29% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-1.45 M Cash From Investing Activities-1.18 M Cash From Operating Activities1.9 M Gross Profit10.81 M
Net Profit-180 K Operating Profit30 K Total Assets82.97 M Total Current Assets59.6 M
Total Current Liabilities15.12 M Total Debt10.05 M Total Liabilities22.1 M Total Revenue24.37 M
Technical Data
High 52 week18.5 Low 52 week7.23 Last close15.3 Last change0.46%
RSI83.07 Average true range0.64 Beta0.33 Volume150.71 K
Simple moving average 20 days16.73% Simple moving average 50 days3.81% Simple moving average 200 days15.02%
Performance Data
Performance Week2.2% Performance Month15.47% Performance Quart13.42% Performance Half9.6%
Performance Year91.97% Performance Year-to-date21.33% Volatility daily3.93% Volatility weekly8.8%
Volatility monthly18.02% Volatility yearly62.44% Relative Volume210.71% Average Volume1.45 M
New High New Low

News

2019-03-12 10:27:28 | See what the IHS Markit Score report has to say about Neogenomics Inc.

2019-03-11 12:59:00 | Here's Why Genetic Testing Stocks Rose as Much as 42.9% in February

2019-03-11 07:00:00 | NeoGenomics Launches Immuno-Oncology Companion Diagnostic Test for Triple Negative Breast Cancer in Conjunction with FDA Approval for TECENTRIQR

2019-03-07 16:50:00 | NeoGenomics To Present At 39th Annual Cowen and Company Health Care Conference

2019-03-05 08:06:29 | See what the IHS Markit Score report has to say about Neogenomics Inc.

2019-02-23 19:09:29 | Back Above $4k: Bitcoin’s Price Jumps to a Two-Month High

2019-02-20 00:40:04 | Edited Transcript of NEO earnings conference call or presentation 19-Feb-19 1:30pm GMT

2019-02-19 14:22:50 | Neogenomics Inc NEO Q4 2018 Earnings Conference Call Transcript

2019-02-19 07:32:41 | NeoGenomics: 4Q Earnings Snapshot

2019-02-19 07:00:00 | NeoGenomics Reports Record Revenue of $76 Million with 17% Organic Revenue Growth in the Fourth Quarter

2019-02-19 06:30:00 | NeoGenomics, Inc. to Host Earnings Call

2019-02-13 08:55:01 | Zacks.com featured highlights include: Ready Capital, Gladstone, NeoGenomics, Digi and Paramount

2019-02-12 15:00:12 | Is NeoGenomics, Inc. NASDAQ:NEO Excessively Paying Its CEO?

2019-02-12 10:30:03 | NeoGenomics NEO Reports Next Week: What to Know Ahead of the Release

2019-02-12 08:19:01 | 5 Breakout Stocks for Stellar Returns

2019-02-08 22:33:00 | Here's Why Genetic Testing Stocks Rose as Much as 31.8% in January

2019-02-08 08:03:12 | See what the IHS Markit Score report has to say about Neogenomics Inc.

2019-01-29 13:10:00 | NeoGenomics Is Poised For Further Gains - Go Long on a Shallow Dip

2019-01-29 09:30:02 | Is NeoGenomics NEO Outperforming Other Medical Stocks This Year?

2019-01-28 07:00:00 | NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2018 Earnings Release for February 19, 2019

2019-01-24 08:07:01 | See what the IHS Markit Score report has to say about Neogenomics Inc.

2019-01-22 19:11:00 | 3 Top Growth Stocks to Buy Right Now

2019-01-18 07:40:00 | Report: Developing Opportunities within Macerich, Illinois Tool Works, NeoGenomics, Bunge, Dolby Laboratories, and Cracker Barrel Old Country Store — Future Expectations, Projections Moving into 2019

2019-01-17 08:03:41 | See what the IHS Markit Score report has to say about Neogenomics Inc.

2019-01-15 08:03:27 | See what the IHS Markit Score report has to say about Neogenomics Inc.

2019-01-09 12:41:00 | Here's Why NeoGenomics Rocketed Higher Today

2019-01-09 08:02:48 | See what the IHS Markit Score report has to say about Neogenomics Inc.

2019-01-08 17:58:00 | NeoGenomics Set to Join S&P SmallCap 600

2018-12-25 09:30:02 | Is NeoGenomics NEO Stock Outpacing Its Medical Peers This Year?

2018-12-21 17:45:10 | NeoGenomics NEO Stock Moves -1.04%: What You Should Know

2018-12-20 08:03:58 | See what the IHS Markit Score report has to say about Neogenomics Inc.

2018-12-19 00:45:45 | NeoGenomics, Inc. NEO: Hedge Funds Are Snapping Up

2018-12-17 10:10:00 | GE Sells Last of Its NeoGenomics Stock for $130 Million

2018-12-14 06:57:11 | The Zacks Analyst Blog Highlights: Anthem, Ensign, NeoGenomics, Merit Medical Systems and Medpace

2018-12-13 10:32:03 | 5 Healthcare Bets to Stay in Investors Good Books Next Year

2018-12-13 07:00:00 | NeoGenomics Appoints Dr. Lawrence M. Weiss as Chief Scientific Officer

2018-12-12 07:35:10 | NeoGenomics Announces Pricing on Secondary Offering of Common Stock by Selling Stockholder

2018-12-11 16:10:00 | NeoGenomics Announces Secondary Offering of Common Stock by Selling Stockholder

2018-12-10 09:10:00 | NeoGenomics Completes Acquisition of Genoptix, Inc.

2018-12-06 09:30:02 | Is NeoGenomics NEO Outperforming Other Medical Stocks This Year?

2018-12-03 09:33:02 | QIAGEN QGEN Partners NeoGenomics to Widen CDx Tests Reach

2018-11-30 17:01:47 | QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugs

2018-11-27 10:44:03 | Eyenovia Initiates Phase III Study for Mydriasis Candidate

2018-11-12 15:00:12 | What Kind Of Investor Owns Most Of NeoGenomics Inc NASDAQ:NEO?

2018-11-12 07:35:00 | Research Report Identifies Ironwood Pharmaceuticals, The AES, Accuray, Ball, Park Hotels & Resorts, and NeoGenomics with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

2018-10-30 15:33:30 | Dow Jones Leads Fragile Rebound; Will This Sector Head A Recovery?

2018-10-30 14:04:38 | Edited Transcript of NEO earnings conference call or presentation 30-Oct-18 12:30pm GMT

2018-10-30 08:35:12 | NeoGenomics NEO Q3 Earnings and Revenues Top Estimates

2018-10-30 07:31:55 | NeoGenomics: 3Q Earnings Snapshot

2018-10-30 07:00:00 | NeoGenomics Reports 17% Revenue Growth to Record $69 Million